The 86K immediate early (IE) 2 protein of human cytomegalovirus trans-activates a number of homologous and heterologous promoters, including the cellular promoter for the 70K heat-shock protein (hsp70), and the human immunodeficiency virus long terminal repeat. We have previously shown that IE2 trans-activates these two promoters in a TATA-dependent manner, and that IE2 is able to form a direct contact with TATA-box binding protein (TBP) in vitro. We now show that IE2 binds to the basic repeat region of TBP. In addition IE2 can contact a second general transcription factor, TFIIB. We have mapped the TBP-and TFIIB-binding regions within IE2 and show that these regions overlap, and also lie within parts of the protein previously identified as being required for the trans-activation and autoregulation functions of IE2.
Introduction
At immediate early (IE) times of human cytomegalovirus (HCMV) infection, RNAs expressed from the major IE promoter-enhancer undergo differential splicing to give two major protein products (Pizzorno et al., 1988; Stenberg et al., 1989 Stenberg et al., , 1990 . These proteins, the 72K IE1 and the 86K IE2, are known to autoregulate their expression. IE1 positively regulates its own expression via 18 base pair repeats in the IE enhancer (Cherrington & Mocarski, 1989) , whereas IE2 negatively autoregulates (Pizzorno et al., 1988) by binding directly to the cis repression signal between the cap site and TATA box of the IE promoter (Lang & Stamminger, 1993; Macias & Stinski, 1993) . In adition, both proteins are independently able to trans-activate a number of minimal homologous (i.e. HCMV) and heterologous (non-HCMV) promoters (Malone et al., 1990; Pizzorno et al., 1991; Stenberg et al., 1990) . Such heterologous promoters include the cellular 70K heat-shock protein (hsp70) promoter (Colberg-Poley et al., 1992; Hagemeier et al., 1992a) , and the human immunodeficiency virus (HIV) long terminal repeat (LTR) (Biegalke & Geballe, 1991 ; Walker et al., 1992) . We have previously shown that both of these promoters are trans-activated by IE1 in a TATAindependent manner, and also that IE1 does not bind to the TATA-binding protein (TBP) in vitro (Hagemeier et al., 1992b) . Conversely, trans-activation of these promoters by tE2 requires the presence of a TATA motif, and IE2 can bind to TBP directly. Similar interactions with TBP have been demonstrated for the viral transcriptional regulators adenovirus Ela (Lee et al., 1991) , Epstein-Barr virus (EBV) BZLF1 (Lieberman & Berk, 1991) , herpes simplex virus (HSV) tegument protein VP16 (Vmw65) (Stringer et al., 1990) and HSV ICP4 (Vmw175) (Smith et al., 1993) . Like Ela and BZLF1, IE2 binds specifically to the C-terminal, but not the Nterminal half of TBP (Hagemeier et al., 1992 b; Lee et al., 1991; Stringer et al., 1990) . Using the same type of in vitro binding assay as previously described, we have investigated in more detail which regions of TBP come into contact with IE2. We now show that, like Ela, IE2 binds to the basic region of TBP, which according to the crystal structure of TBP lies on the outer convex surface of the protein (Nikolov et al., 1992) , and that the presence of this region is an absolute requirement for binding. However IE2 and Ela differ in that IE2 requires the presence of an additional TBP sequence in one of the flanking repeats to give full binding, whereas the basic region alone is sufficient for full Ela binding.
We have likewise asked which regions of IE2 are responsible for the binding to TBP, and show that specific interaction is mediated via a region in exon 5 of IE2. Although this region does not include the C-terminal independent activation domain as identified by GAL4 fusion experiments, it does include regions that have been shown to be important for the trans-activation of HCMV early promoters and heterologous promoters by IE2, and also for IE2-mediated autoregulation (Hermiston et al., 1987; Pizzorno et al., 1991; Stenberg et al., 1990) . Interestingly, the removal of the N-terminal half of IE2 (amino acids 1 to 290) results in a large increase in the binding of TBP in vitro.
In addition to binding to TBP, the HSV transcriptional regulators VP16 and ICP4 are also known to interact directly with a second general transcription factor, TFIIB (Lin & Green, 1991; Smith et al., 1993) . We now show that this feature is shared by IE2. The region of IE2 that mediates binding to TFIIB overlaps with that required for TBP binding, and this also appears to be the case for VP16 (Lin & Green, 1991) .
Methods
Plasmids. pBS-IE2, a full-length HCMV IE2 cDNA clone under the control of the T7 promoter, was made by cloning a SalI fragment covering the IE2 coding sequence from priM121 (Plachter et al., 1993) into BlueScript II KS. Other plasmids for in vitro expression of IE2 were constructed in the vector series pGH253 to -255; these allow coding sequences to be cloned in frame behind the black beetle virus leader and initiator region sequences (Lieberman et al., 1990) , under the control of the T7 promoter. The complete exon 5 coding region of IE2 (codons 86 to 579) was amplified by PCR from the genomic HCMV (Towne) IE effector plasmid pRL45 (Pizzorno et al., 1988) using the linker primers LGH320 and LGH369 (Pizzorno et al., 1991) , and cloned into the BglII site of pGH253 to give pCJC182. The same primers were used to amplify the coding sequence for amino acids 290 to 579 from a pRL45-derived template containing an in-frame BglII insertion linker at the XhoI site (pMP32); the PCR fragment was then cloned into the BglII site of pGH255 to give pGH313. The coding region for exons 2 and 3 (codons 1 to 85) was amplified using linker primers LGH401 and LGH367 (Pizzorno et al., 1991) , and the fragment was then cloned into the BamHLSacI sites ofpGH255 to give pCJC185.
Generation of in vitro translated proteins. Vectors for in vitro expression of E1A (pTM1E1A), TBP (pKB104), IE1 (pSV2IE1) and gelsolin were as previously described (Hagemeier et al., 1992b) . Plasmid phIIB, for expression of TFIIB, was provided by Dr D. Reinberg (University of Medicine and Dentistry of New Jersey, N.J., U.S.A.). For IE2 expression, in vitro transcription/translation of EcoRI-linearized pBS-IE2 generated wild-type IE2 (amino acids 1 to 579); fragments of IE2 were made by expression from pCJC185/EcoRI, pCJC182/XhoI and pBS-IE2/XhoI to give polypeptides covering residues 1 to 85, 86 to 290 and 1 to 290, respectively. Digestion of pGH313 with either DraII1, HaeII, Stul or EcoRI, followed by transcription/translation, generated fragments of IE2 covering residues 290 to 390, 290 to 504, 290 to 542 or 290 to 579, respectively. Procedures for digestion and transcription/translation were as described (Hagemeier et al., 1992b; Kouzarides & Ziff, 1988) .
GSTfusion proteins, pGEX.TBP-C and pGEX.TBP-N have been described previously (Hagemeier et al., 1992b) . To make pGEX.TBP (residues 168 to 202) a SspI-BspHI fragment of pKBI04 was filled in, and inserted at the SmaI site of pGEX-3X. To generate pGEX. TBP (residues 202 to 272), pGEX.TBP (residues 202 to 339) and pGEX.TBP (residues 272 to 339), BspHI StuI, BspHI-DraI and StuI-DraI fragments from pKB104 respectively were filled in where necessary, and cloned into the SmaI site of pGEX-2T, pGEX.TBP (residues 168 to 272) was constructed by removing a StuI-EcoRI fragment from pGEX.TBP-C, filling in the EcoRI site and then religating the plasmid (Hagemeier, 1992) . pGEX.TBP was made by cloning a blunt-ended AlwI-EcoRV fragment from pKB104, which covers all but the first three codons of the TBP coding sequence, into the SmaI site of pGEX-3X in frame with the glutathione S-transferase (GST) gene. pGEX.TFIIB was made by PCR amplification of the TFIIB coding sequence of phIIB. Primers were constructed to introduce BamHI and EcoRI sites at the 5' and 3' ends respectively, to allow the product to be inserted in frame into the BarnHI EeoRI sites of pGEX-2T; primer sequences were 5'CTGTGGATCCACCCGCCGTT-TGGATGC and 3' ACGGAATTCGACGTTAGCTGCCTC. pGEX-3X. IE 1 was made as follows: a SmaI site was introduced just upstream of the IE1 initiation codon in pSV2IE1 by site-directed mutagenesis; a SmaI XbaI fragment covering the complete IE1 coding sequence was then isolated from the resulting plasmid (pSV2SmaIE1), blunt-ended and ligated in frame into the SmaI site of pGEX-3X. To make pGEX-3X. IE2, a HpaI-EcoRI fragment, covering exons 3 and 4 of IE1, was excised from pGEX-3X.IE1, and replaced by the HpaI-EcoRI fragment from pBS-IE2, to introduce exon 3 (common to IE1 and IE2) and exon 5 (unique to IE2). GST fusion protein expression and purification were as described (Smith & Johnson, 1988) , and all constructs produced in-frame fusions with GST of the expected M r.
In vitro protein protein binding assay. GST fusion protein (500 ng) on beads was preincubated with BSA at room temperature in a final concentration of 1 mg/ml BSA for 5 min and then rocked for 1 h at room temperature with 2 to 5 gl of in vitro translated test protein in a final volume of 200 gl in EBC buffer (140 mM-NaC1, 0.5% NP40, 100 mM-NaF, 200 laM-sodium orthovanadate, 50 mM-Tris-HC1 pH 8-0). The beads were then washed three times in 1 ml of NETN buffer (100mM-NaC1, 1 mM-EDTA, 0.5% NP40, 20mM-Tri~HCI pH 8.0), centrifuged at 1000 r.p.m, for 30 s and then boiled in 4 x SDS sample buffer. Bound proteins were resolved on SDS polyacrylamide gels and detected by autoradiography. All experiments were repeated at least three times, and representative results are shown.
Generation of32P-labelled GST fusion proteins.
To allow 3ZP-labelling of IE1 and IE2-GST fusions, BamHI-EcoRI fragments covering the coding sequence of IE1 or IE2 were isolated from pGEX-3X.IE1 or pGEX-3X.IE2 respectively, blunt-ended and ligated into the bluntended BamHI site of pGEX-2TK, which was a kind gift of Dr W. Kaelin (Kaelin et al., 1992) . After expression and purification of the fusion proteins (Smith & Johnson, 1988) , labelling and elution were carried out exactly as described (Kaelin et al., 1992) .
Far Western blotting. Western blotting of crude bacterial extracts containing various GST fusions was carried out exactly as previously described (Hagemeier et al., 1992b) . Filters were then probed with either 32P-labelled GST-IE1 or GST-IE2 (100000 c.p.m./ml) in 10 ml hybridization buffer supplemented with a crude bacterial extract prepared from cells expressing the GST polypeptide from plasmid pGEX-2TK, as described (Kaelin et al., 1992) . Probes were normalized for 32p incorporation by using scintillation counting, and by using SDS-PAGE followed by autoradiography.
Results

IE2 binds to the basic region and N-terminal flanking repeat of TBP
GST fusions to various regions of the C terminus of TBP were constructed (Fig. 1 a) and assayed for their ability to bind either Ela or IE2. Ela binds with equal strength to Consistent with earlier findings (Lee et al., 1991) , there is no binding to fusions lacking the basic region ( Fig. 1 b,  lanes 3 and 4) . The presence of either the N -t e r m i n a l or C-terminal flanking repeat does not increase the a m o u n t of E l a b o u n d (Fig. l b , lanes 5 and 6 respectively), indicating that the basic region of TBP is b o t h necessary and sufficient for full binding of E 1 a. Like E l a , 1E2 is also able to bind to the basic region of TBP in isolation (Fig. 1 c, lane 2) , and there is no binding to fusions lacking this region. H o w e v e r in contrast to E l a , the binding o f IE2 to the basic region alone is significantly reduced with respect to binding to the entire C-terminal of TBP (Fig. 1 c, lane 2) . Full binding of IE2 is restored by the additional presence of residues 168 to 201, covering the N -t e r m i n a l flanking repeat ( Fig. 1 c, lane 5) , but not by the C-terminal repeat. Therefore although the basic region is necessary for the binding of IE2, it is not sufficient to give m a x i m a l interaction, which also requires the complete N -t e r m i n a l repeat of TBP. 
Binding of lE2 to TBP is mediated via a C-terminal region of IE2
F r a g m e n t s of IE2 were expressed in vitro (Fig. 2a) and used in p r o t e i n -p r o t e i n binding assays with G S T fusions to either the C-terminal or N -t e r m i n a l half of TBP. Nterminal fragments of IE2, covering sequences up to amino acid residue 290, do not bind to either G S T fusion construct, nor does a fragment covering residues 290 to 390 ( Fig. 2b and c, lanes 1 to 4) . However, fragments containing an additional IE2 C-terminal sequence, up to residues 504, 542 or 579, all bind strongly to the C terminus of the TBP fusion construct. (Fig. 2b , lanes 5 to . In fact, these three IE2 constructs bind much more strongly to GST-TBP-C than does full-length IE2 (Fig.  2b, lane 8) . This effect is reproducible and was also seen in binding assays using a full-length GST-TBP fusion (results not shown), and shows not only that isolated N-terminal regions of IE2 are unable to bind to TBP (Fig. 2b, lanes 1 to 3) , but that in the context of the entire protein, the residue 1 to 290 region of IE2 contains a region (or regions) that actually reduces the binding to TBP. Since the four C-terminal IE2 input proteins are of approximately equal intensity (Fig. 2a, lanes 4 to 7) , it is clear that the majority of specific binding to TBP-C is conferred by a region of IE2 between residues 290 and 504 (Fig. 2b, lane 5) , and the presence of additional Cterminal sequences has little effect on the amount of protein bound. None of the IE2 fragments was able to bind to the GST-TBP-N (Fig. 2c) , confirming that the interactions seen here are specific for the C terminus of TBP. These results show that a region of IE2 between amino acids 290 and 504 is sufficient for binding to TBP, and that the entire N-terminal half of IE2 (residues l to 289) is dispensable for binding. The IE2 fragment covering residues 290 to 390 was not able to bind TBP in isolation, but our results do not indicate whether or not this region actually contributes to TBP binding by the IE2 residues 290 to 504 fragment.
IE2 binds directly to TFIIB
Since the viral transcription factors VP16 and ICP4 can interact with TFIIB in addition to TBP, we examined whether IE2 is also able to bind to TFIIB. Fig. 3(b) shows that IE2, but not IE1, is able to bind to a GST TFIIB fusion; however, the binding of IE2 to TFIIB appears to be much weaker than that seen with TBP, as judged by the amount of input IE2 which is retained on the target GST fusion constructs (compare lanes 2 of Fig. 3 b and Fig. 3 c) .
To confirm the IE2-TFIIB interaction, we carried out Far Western analysis. Bacterial extracts containing either the GST polypeptide alone, or GST fusions to either TBP or TFIIB were separated by SDS PAGE, blotted and probed with z~P-labelled GST-IE1 or GST-IE2. Fig.  4(b) shows that the IE2 probe binds to both the TBP and TFIIB fusions, but not to the GST polypeptide alone. It should be noted that the binding of IE2 to TFIIB appears to be higher than that to TBP (compare lanes 2 and 3 of Fig. 4b) ; this is due to the far higher concentration of GST-TFIIB in the bacterial extract compared with that of GST-TBP (Fig. 4a) , whereas in the experiment shown in Fig. 3 , using purified fusion proteins on beads, both target proteins were of approximately equal concentration. As expected, the IE1 probe does not bind to any of the GST constructs. These data not only confirm the IE2 TFIIB interaction but also, since the protein probes were expressed in and purified from bacteria, demonstrate that the binding of IE2 to both TBP and TFIIB is direct, and does not require the presence of any other eukaryotic factor.
In the same manner as for TBP, we examined which regions of IE2 are responsible for TFIIB binding. As seen with TBP-C, neither N-terminal fragments of IE2 nor the residues 290 to 390 fragment were able to bind to T F I I B (Fig. 5b, lanes 1 to 4) . The residues 290 to 504 fragment of IE2 showed some binding to T F I I B (Fig. 5 b, lane 5), but this was much less than that seen with the same IE2 fragment binding to the TBP-C fusion, and the optimum binding required the additional presence of amino acids 505 to 542 (Fig. 5 b, lane 6) . Again, the three longer C-terminal fragments all bind more strongly to T F I I B than does full-length IE2; in fact at this exposure the binding o f full-length IE2 in Fig. 5 (b) lane 8 is not visible, but can clearly be seen on longer exposures of the same gel (not shown). Therefore the residues 505 to 542 region of IE2 is necessary to give full binding to TFIIB, whereas the residues 390 to 504 region also forms part o f the binding domain. As before, we cannot preclude a role for the residues 290 to 390 region o f IE2, although clearly this region in isolation is not sufficient for T F I I B binding.
D i s c u s s i o n
Previously we demonstrated that the T A T A -d e p e n d e n t trans-activation of the H I V L T R and the hsp70 promoter by IE2 is similar to that by adenovirus Ela, and that both proteins specifically interact with the C-terminal half o f TBP (Hagemeier et al, 1992 b) . These findings are consistent with the observation that IE2 is able to complement Ela-deficient mutants of adenovirus (Tevethia & Spector, 1984 . However, the two proteins differ in their precise requirement for binding to TBP sequences: we find that E1 a appears to require only the basic region o f TBP for full binding, in agreement with previous findings (Lee et al., 1991) ; by contrast, although IE2 is able to bind the basic region in isolation, it requires additional regions in the N-terminal flanking repeat o f TBP to maximize the strength of the interaction. The crystal structure of TBP indicates that both these regions lie on the outer convex surface of the TBP molecule, and would therefore be a potential target for interactions with other transcription factors (Nikolov et al., 1992) . Given that IE2 and E l a differ in their binding to TBP, it is interesting to note that the two proteins also differ in their precise requirements for a T A T A motif for their trans-activation of promoters. Whereas E l a requires the promoter-specific T A T A box for efficient trans-activation, IE2 is more promiscuous in the sense that it is able to trans-activate promoters containing a simian virus 40 early promoter T A T A element as effectively as it does the wild-type promoters (Hagemeier et al., 1992b; Malone et al., 1990) . We show that the TBP and T F I I B binding regions of IE2 overlap but are not identical (see the schematic in (Hermiston et al., 1987; Malone et al., 1990; Pizzorno et al., 1991; Stenberg et al., 1990) . The TBP and TFIIB binding regions are shown as filled boxes. Numbering indicates the positions of these regions in the amino acid sequence of IE2.
of this, we have found that IE2 can interact directly in vitro with the retinoblastoma (RB) protein, and that this IE2 function maps outside the region required for TBP and TFIIB binding (C. Hagemeier, R. C. Caswell, G. P. Hayhurst, J. Sinclair & T. Kouzarides, unpublished) . It is also interesting to note that the region of IE2 which is essential for full binding to TFIIB is also involved in IE2 homodimerization (Chiou et al., 1993; Furnari et al., 1993) , and in fact there is significant sequence identity between this region of IE2 and the inter-repeat and flanking regions of TFIIB (R. C. Caswell & J.H. Sinclair, unpublished) . Given this, an alternative interpretation of our results, and one that we cannot preclude, is that the TFIIB binding region lies entirely between residues 290 and 504, but that dimerization of IE2 is necessary for binding to TFIIB. This would mean that although smaller IE2 fragments might contain the TFIIB binding region, IE2-TFIIB interactions would not be seen without the presence of a homodimerization domain. A recent report by Furnari et al. (1993) has demonstrated specific binding to a GST-IE2 affinity column by a number of proteins in nuclear extracts of human lung fibroblasts, one of which was identified as TBP. The observation that TBP binds specifically to GST-IE2 when present in a complex mixture of nuclear proteins, taken together with our previous report that transactivation of promoters by IE2 is TATA-dependent (Hagemeier et al., 1992b) , strongly supports the view that the interactions we report here are of physiological significance. The TBP and TFIIB binding regions map within sequences of IE2 which have previously been shown to be important both for trans-activation and autoregulation. For instance, Hermiston et al. (1987) and Pizzorno et al. (1991) have shown by using cotransfection assays that amino acids 195 to 579 of exon 5 are essential for efficient trans-activation, but that regions in the N-terminal region of exon 5 (amino acids 99 to 194) are dispensable (see Fig. 6 ). Our data indicate that the regions of IE2 that are important for binding TBP and TFIIB lie within this essential residues 195 to 579 region of exon 5, whereas the residues 98 to 194 region of IE2 which is not required for trans-activation also does not contribute to binding of TBP or TFIIB. Moreover, it has recently been shown that the C-terminal half of IE2 (amino acids 290 to 579) is sufficient to mediate specific repression of transcription from the HCMV major IE promoter in vitro (Macias & Stinski, 1993) . This IE2 construct resembles the late isoform of IE2 (comprising amino acids 242 to 579) which possesses autoregulation but not trans-activation function (Malone et al., 1990; Pizzorno et al., 1991) . Since the residues 290 to 579 fragment of IE2 binds strongly to both TBP and TFIIB in vitro (see Fig. 3 and Fig. 5 ), our results suggest that the failure of the late isoform of IE2 to trans-activate gene expression is not due to an inability of IE2 to bind to these factors, but rather is due to the lack of other, as yet undefined functions in exons 2 and 3. In this respect, it is noteworthy that exon 3 contains one of the independent activation domains, as defined by GAL4 fusion experiments (Pizzorno et al., 1991) . Similarly, for Ela it has been shown that although TBP binding is necessary for trans-activation, it is not sufficient, since a point mutant of Ela that bound to TBP as strongly as did wild-type Ela was only a poor transactivator (Lee et al., 1991; Martin et al., 1990) .
One of the proposed models for Ela action is that it activates TBP function by increasing the DNA-binding affinity of TBP (Lee et al., 1991) , as has been shown for the EBV trans-activator BZLF1 which reduces the 'off' rate of bound TBP from TATA elements (Lieberman & Berk, 1991) . However, preliminary experiments using purified recombinant proteins suggest that IE2 does not increase the specific binding of TBP to a TATA element in electrophoretic mobility shift assays (R. C. Caswell & J. H. Sinclair, unpublished). The observation that IE2 is capable of binding to both TFIIB and TBP, and that the binding regions overlap but are not identical, implies that IE2 may be capable of interacting with both factors simultaneously. This suggests a second model by which IE2 might act through general transcription factors, that is by increasing the rate of assembly of the pre-initiation complex. As previously mentioned, the HSV transcriptional regulators VPt6 and ICP4 have been shown to interact directly with both TBP and TFIIB (Lin & Green, 1991 ; Stringer et al., 1990; Smith et al., 1993) . In common with IE2, experiments using mutant VP16 proteins show that the binding regions for TBP and TFIIB overlap (Lin & Green, 1991) . In the case of ICP4, the region that mediates protein-protein interactions in the ICP4-TBP-TFIIB-DNA complex maps between amino acids 142 and 274 (Smith et al., 1993) , and this region has previously been shown to be involved in transactivation (Shepard et al., 1989) . Both these transactivator proteins appear to function at least in part by binding to and stabilizing the TBP TFIIB-DNA complex (Lin & Green, 1991; Stringer et al., 1990; Smith et al., 1993) , and we are currently investigating whether IE2 can function in a similar fashion. In a third model of Ela function, Ela acts as an adaptor of the sequence-specific DNA-binding factor ATF-2, which binds to cognate sites upstream of the promoter (Lillie & Green, 1989; Liu & Green, 1990) , thereby bridging between upstream bound ATF-2 and the basal transcription complex. Given its ability to complement Ela-deficient mutants of adenovirus, this may also be a possible mechanism for IE2 function, and we are currently screening a range of factors for physical and functional interactions with IE2.
Additionally, the recent observation that IF2 can bind DNA directly at the cis repression signal between the TATA box and cap site of the HCMV major IE promoter-enhancer, thereby effecting negative autoregulation (Lang & Stamminger, 1993 ; Macias & Stinski, 1993) 
